Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-03-14 @ 5:48 AM
Study NCT ID:
NCT05604651
Status:
COMPLETED
Last Update Posted:
2022-11-23
First Post:
2022-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Mucin Levels at the Ocular Surface of Visual Display Users With and Without Dry Eye Disease
Sponsor:
Peking University Third Hospital
Organization:
Study Overview
Official Title:
Comparison of Mucin Levels at the Ocular Surface of Visual Display Users With and Without Dry Eye Disease
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study aimed to evaluate 1) if levels of the glycocalyx membrane mucins, including MUC1, MUC4, MUC16 and MUC20, are altered in conjunctival cells of visual display users With and Without Dry Eye Disease, and 2) if mucin levels correlate with dry eye clinical diagnostic data.
Detailed Description:
The cross-sectional study aimed to evaluate 1) if levels of the glycocalyx membrane mucins, including MUC1, MUC4, MUC16 and MUC20, are altered in conjunctival cells of visual display users With and Without Dry Eye Disease, and 2) if mucin levels correlate with dry eye clinical diagnostic data.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: